Pfizer
Pharmaceutical giant Pfizer develops and produces medicines and vaccines for a variety of chronic diseases and conditions. The company, founded in 1872, has several blockbuster products that each generate more than $1 billion in revenue per year, including Prevnar 13, a pneumococcal conjugate vaccine; Ibrance, a breast cancer treatment; and Eliquis, which helps prevent strokes in at-risk people. On Dec. 11, 2020, to help combat the coronavirus pandemic, the U.S. Food and Drug Administration authorized Pfizer and BioNTech’s COVID-19 vaccine for emergency use, the first of three given a green light in the U.S. As of May 26, half of all adults in the U.S. have been fully vaccinated against COVID-19, in large part due to the Pfizer-BioNTech shot.
Daniel Acker—Bloomberg via Getty Images
Company Information
As of 6/5/23
Country/Territory
U.S.
Headquarters
New York City
Industry
Pharmaceuticals
CEO
Albert Bourla
Website
Company Type
Public
Ticker
PFE
Revenues ($M)
$100,330
Profits ($M)
$31,372
Market Value ($M)
$230,292
Employees
83,000
Market value as of March 31, 2023.
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
5.47
EPS % Change (from 2021)
42.1%
EPS % Change (5 year annual rate)
9.2%
EPS % Change (10 year annual rate)
10.9%
Total Return
Total Return to Investors (2022)
-10.3%
Total Return to Investors (5 year, annualized)
12.3%
Total Return to Investors (10 year, annualized)
11.9%
America's Most Innovative Companies
Sector
Health Care
Culture rank
155
Process rank
138
Product rank
17
World's Most Admired Companies
Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
8
Previous All-Star Rank
4
Industry Rank
4
Previous Industry Rank
4
Overall Score
7.53
Innovation
5
People Management
3
Use of Corporate Assets
6
Social Responsibility
5
Quality of Management
2
Financial Soundness
2
Long-Term Investment Value
6
Quality of Products/Services
2
Global Competitiveness
3
Key Financials (Last Fiscal Year)
($ Millions)
% change
Revenues ($M)
$81,288
94%
Profits ($M)
$21,979
128.6%
Assets ($M)
$181,476
-
Total Stockholder Equity ($M)
$77,201
-
Profit Ratios
Profit as % of Revenues
27%
Profits as % of Assets
12.1%
Profits as % of Stockholder Equity
28.5%
Lists ranking Pfizer
Latest news for Pfizer
- Novavax CEO on why his Covid vaccine is "demonstrably better" than Pfizer and Moderna;7:03Series, On Leading;
- Brainstorm Health 2022 - Burned Out: Tackling Well-Being And Mental Resilience In The Workplace;19:05Conferences, Brainstorm Health;
- Brainstorm Health 2022 - Leveraging New Frontiers: The Importance Of A Global Strategy ;21:29Conferences, Brainstorm Health;
- FDA recommends second booster for ages 50 and older;1:28News, Raw;